title: [Autoimmune blistering skin diseases: diagnostic and therapeutic approach].
authors.affiliation: Klinik für Dermatologie, Allergologie und Venerologie, Universität zu Lübeck, Lübeck.
authors.forename: C M
authors.initials: CM
authors.lastname: Hammers
authors.affiliation: Klinik für Dermatologie, Allergologie und Venerologie, Universität zu Lübeck, Lübeck.
authors.forename: E
authors.initials: E
authors.lastname: Schmidt
authors.affiliation: Klinik für Dermatologie, Allergologie und Venerologie, Universität zu Lübeck, Lübeck.
authors.forename: D
authors.initials: D
authors.lastname: Zillikens
mesh_terms: D000305:Adrenal Cortex Hormones / Q000009:adverse effects / Q000627:therapeutic use; D058846:Antibodies, Monoclonal, Murine-Derived / Q000009:adverse effects / Q000627:therapeutic use; D001323:Autoantibodies / Q000097:blood; D001327:Autoimmune Diseases / Q000175:diagnosis* / Q000188:drug therapy / Q000276:immunology; D003131:Combined Modality Therapy; D003937:Diagnosis, Differential; D004359:Drug Therapy, Combination; D019983:Guideline Adherence; D006801:Humans; D007163:Immunosorbent Techniques; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use; D010391:Pemphigoid, Bullous / Q000175:diagnosis* / Q000188:drug therapy / Q000276:immunology*; D010392:Pemphigus / Q000175:diagnosis* / Q000188:drug therapy / Q000276:immunology*; D000069283:Rituximab; D012872:Skin Diseases, Vesiculobullous / Q000175:diagnosis* / Q000188:drug therapy / Q000276:immunology*
chemical_list: D000305:Adrenal Cortex Hormones; D058846:Antibodies, Monoclonal, Murine-Derived; D001323:Autoantibodies; D007166:Immunosuppressive Agents; D000069283:Rituximab